Our experience in biotechnology is comprehensive. We have assisted clients with complex IP challenges in the fields of microbiology, vaccines, gene editing technology, antibody therapies, genomics, proteomics, and stem cell therapies.

Our attorneys have acted in key disputes involving CRISPR-Cas9 gene editing technology and developed and implemented protection and FTO strategies to permit the unhindered clinical development of disruptive microbiome therapies.

We bring a sharp legal focus and a wealth of experience with clients ranging from spin-outs and start-ups to blue chip companies in this highly competitive sector.


We have extensive experience in securing patents, trade marks and registered design rights on your behalf and have prepared, filed, and prosecuted IP rights worldwide.

Find out more